EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H17N3O3 |
| Net Charge | 0 |
| Average Mass | 287.319 |
| Monoisotopic Mass | 287.12699 |
| SMILES | CCCCNC(=O)c1cnc(-c2ccc(O)cc2)c(=O)n1 |
| InChI | InChI=1S/C15H17N3O3/c1-2-3-8-16-14(20)12-9-17-13(15(21)18-12)10-4-6-11(19)7-5-10/h4-7,9,19H,2-3,8H2,1H3,(H,16,20)(H,18,21) |
| InChIKey | HURXYEZMLXEXLD-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. |
| Applications: | antitubercular agent A substance that kills or slows the growth of Mycobacterium tuberculosis and is used in the treatment of tuberculosis. prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-butyl-5-(4-hydroxyphenyl)-6-oxo-1,6-dihydropyrazine-2-carboxamide (CHEBI:167182) is a pyrazinecarboxamide (CHEBI:45285) |
| IUPAC Name |
|---|
| N-butyl-5-(4-hydroxyphenyl)-6-oxo-1,6-dihydropyrazine-2-carboxamide |
| Synonym | Source |
|---|---|
| N-butyl-1,6-dihydro-5-(4-hydroxyphenyl)-6-oxo-2-pyrazinecarboxamide | ChEBI |
| Citations |
|---|